Successful erlotinib rechallenge after gefitinib-induced acute interstitial pneumonia

J Thorac Oncol. 2010 Jul;5(7):1105-6. doi: 10.1097/JTO.0b013e3181dc39cd.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adenocarcinoma / drug therapy*
  • Adenocarcinoma / secondary
  • Aged
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Erlotinib Hydrochloride
  • Female
  • Gefitinib
  • Humans
  • Lung Diseases, Interstitial / chemically induced*
  • Lung Diseases, Interstitial / drug therapy
  • Lung Neoplasms / drug therapy*
  • Lung Neoplasms / pathology
  • Middle Aged
  • Quinazolines / administration & dosage
  • Survival Rate
  • Tomography, X-Ray Computed
  • Treatment Outcome

Substances

  • Quinazolines
  • Erlotinib Hydrochloride
  • Gefitinib